Similar articles for PMID: 27412366

Year	Number of Results
1985	1
1989	1
1990	1
1991	1
1992	1
1994	1
1996	1
1997	2
1998	3
1999	1
2000	1
2002	1
2005	1
2006	2
2007	4
2008	1
2009	2
2010	1
2013	3
2014	3
2015	3
2016	3
2017	1
2024	0

1

Pharmacokinetic Profile of Oral Magnesium Hydroxide.

Dolberg MK, Nielsen LP, Dahl R. Dolberg MK, et al. Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):264-269. doi: 10.1111/bcpt.12642. Epub 2017 Jan 11. Basic Clin Pharmacol Toxicol. 2017. PMID: 27412366 Free article. Clinical Trial.

2

Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.

Chen C, Bujanover S, Kareht S, Rapoport AM. Chen C, et al. Headache. 2015 Feb;55(2):265-75. doi: 10.1111/head.12483. Epub 2014 Dec 24. Headache. 2015. PMID: 25546369 Clinical Trial.

3

A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L. Marcelín-Jiménez G, et al. Clin Ther. 2009 Sep;31(9):2002-11. doi: 10.1016/j.clinthera.2009.09.016. Clin Ther. 2009. PMID: 19843490 Clinical Trial.

4

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.

Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A. Ramael S, et al. Clin Ther. 2006 May;28(5):734-44. doi: 10.1016/j.clinthera.2006.05.004. Clin Ther. 2006. PMID: 16861095 Clinical Trial.

5

Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.

Mück W, Ritter W, Dietrich H, Frey R, Kuhlmann J. Mück W, et al. Int J Clin Pharmacol Ther. 1997 Jun;35(6):261-4. Int J Clin Pharmacol Ther. 1997. PMID: 9208343 Clinical Trial.

6

Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected?

Christensen HR, Antonsen K, Simonsen K, Lindekaer A, Bonde J, Angelo HR, Kampmann JP. Christensen HR, et al. Pharmacol Toxicol. 2000 Apr;86(4):178-82. doi: 10.1034/j.1600-0773.2000.d01-32.x. Pharmacol Toxicol. 2000. PMID: 10815751 Clinical Trial.

7

Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.

Göhler K, Brett M, Smit JW, Rengelshausen J, Terlinden R. Göhler K, et al. Int J Clin Pharmacol Ther. 2013 Apr;51(4):338-48. doi: 10.5414/CP201722. Int J Clin Pharmacol Ther. 2013. PMID: 23357834 Clinical Trial.

8

Clinical study on the influence of a fixed-dose combination of famotidine with calcium carbonate and magnesium hydroxide on the bioavailability of famotidine.

Zhai Q, Fu J, Huang X, Xu B, Yuan YZ, Jiang T, Rong ZX, Chen HZ. Zhai Q, et al. Arzneimittelforschung. 2008;58(11):581-4. doi: 10.1055/s-0031-1296560. Arzneimittelforschung. 2008. PMID: 19137909 Clinical Trial.

9

Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.

Radwanski E, Nomeir A, Cutler D, Affrime M, Lin CC. Radwanski E, et al. Am J Ther. 1998 Mar;5(2):67-72. Am J Ther. 1998. PMID: 10099040 Clinical Trial.

10

The effect of antacid and ranitidine on droxicam pharmacokinetics.

Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J. Bartlett A, et al. J Clin Pharmacol. 1992 Dec;32(12):1115-9. J Clin Pharmacol. 1992. PMID: 1487550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year